Hoth Therapeutics shares are trading higher after the company signed an agreement with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype for Alzheimer's disease.
Portfolio Pulse from Benzinga Newsdesk
Hoth Therapeutics shares are trading higher after the company signed an agreement with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype for Alzheimer's disease.
July 24, 2024 | 10:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hoth Therapeutics shares are trading higher following the announcement of a partnership with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype for Alzheimer's disease.
The partnership with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype is a significant step for Hoth Therapeutics, potentially leading to advancements in Alzheimer's treatment. This positive development has led to a rise in Hoth's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100